Given this specific identification of DYRK1A as a potential driver in KMT2A-R ALL via our CRISPR screen, we then hypothesized that oncogenic KMT2A rearrangements may directly regulate DYRK1A expression. Here, KMT2A is linked to acute lymphoblastic leukemia.